US00287YDR71 · Corp · USD

Abbvie Inc 4.80% 2027/03

Abbvie IncUnited StatesGLOBALSenior Unsecured
MID PRICE
101.20
par = 100
YIELD TO MAT.
4.08%
semi-annual
COUPON
4.800%
semi-annual · fixed
MATURITY
2027-03-15
bullet · 0.86y
OUTSTANDING
not disclosed
AS OF
2026-04-30
Fund disclosure

Sign up free to see prices on this bond

Free accounts get 40 bond price views per month — 4× the anonymous quota. Pro is unlimited.

About this bond

AI BRIEF · GROUNDED IN STRUCTURED DATA
About the issuer

AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. They have produced drugs to treat a wide range of medical issues.

Source: Wikipedia →

Risk analytics

SEMI-ANNUAL · BULLET · PAR 100
Modified duration
0.83 y
1bp ↑ ≈ -0.008% P&L
Convexity
1.11
higher = more curvature
Years to maturity
0.86 y
YTM source
Ingested
Fund disclosure
Market signals · funds disclosing this bond
SignalCategoryExposureLast moveWeightAs of
iShares iBonds Dec 2027 Term Corporate
iShares
iBonds 2027 Corporate$15.9M▲ $7K0.42%2026-04-30
State Street Ultra Short Term Bond
SPDR
US Ultra Short$4.5M▲ $1K0.75%2026-04-30
Subscribe to reveal which signals are holding this bond.Subscribe →

Price history

Sherpa Signal

AS OF 2026-04-30

Institutional footprint · signal-level holdings

28/ 100Early footprint
Interpretation. Light institutional footprint, holding
HOLDERS
2
unchanged in 7d
AGGREGATE EXPOSURE
$20.4M
USD across all
TOP CONCENTRATION
77.9%
largest holder
FLOW
▲ $78K
unchanged in 7d

Sherpa Signal is derived from a panel of tracked institutional portfolios. Names of individual holders are not disclosed.

100K PAR NOTIONAL · MARKET VALUE
101,204 USD
PRICE
101.20

RFQ routing · coming soon

Security details

VIA OPENFIGI
Canonical
ABBV 4.8 03/15/27
FIGI
BBG01LNT0GJ7
CUSIP
00287YDR7
ISIN
US00287YDR71
Type
Corp
Issued
2024-02-26
Face value
100 USD
Ticker
ABBV 4.8 03/15/27
Sec. type
GLOBAL
Seniority
Senior Unsecured

Issuer curve

ABBV · 10 PTS

Yield (%) plotted against years-to-maturity. This bond highlighted in amber.